Sunshine Biopharma (SBFM) Return on Capital Employed Growth (1y) (2017 - 2026)
Sunshine Biopharma (SBFM) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 89.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 448.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -1,715.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,309.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 999.00 |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | -368.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -368.00 |
| Dec 31, 2025 | -157.00 |
| Sep 30, 2025 | -629.00 |
| Jun 30, 2025 | -785.00 |
| Mar 31, 2025 | -492.00 |
| Dec 31, 2024 | -210.00 |
| Sep 30, 2024 | 9,809.00 |
| Jun 30, 2024 | 10,307.00 |
| Mar 31, 2024 | 11,139.00 |
| Dec 31, 2023 | 7,409.00 |
| Sep 30, 2023 | -10,806.00 |
| Jun 30, 2023 | -11,143.00 |
| Mar 31, 2023 | -9,918.00 |
| Dec 31, 2022 | 1,191.00 |
| Sep 30, 2022 | 13,878.00 |
| Jun 30, 2022 | 16,282.00 |
| Mar 31, 2022 | 27,810.00 |
| Dec 31, 2021 | -33,565.00 |
| Sep 30, 2021 | -26,838.00 |
| Jun 30, 2021 | -29,613.00 |